4-Antibody is a wholly owned subsidiary of Agenus Inc. with strong, commercially-experienced leadership located in Basel, Switzerland and Jena, Germany. 4-Antibody has a powerful fully-human antibody drug-discovery technology platform, which is generating an emerging pipeline of antibody therapeutics focused on cancer immunotherapy. The proprietary discovery engine is the in-vitro Retrocyte Display® technology, a fast and highly efficient source of antibody drug candidates. Retrocyte Display generates high quality therapeutic antibody drug candidates quickly using a rapid, high-throughput, flow cytometry approach incorporating full-length IgG format human antibody libraries expressed in mammalian B cells (the cell designed by nature for optimal antibody display).
Forschung & Entwicklung